M2R
0.003
50%
BIT
0.002
-33.3%
XEN
0.003
50%
HYD
0.003
-25%
BUY
0.019
46.2%
QPM
0.009
-25%
OEL
0.007
40%
PXA
8.54
-21.3%
PR2
0.028
40%
HIQ
0.008
-20%
ZEU
0.007
40%
BNL
0.005
-16.7%
AQX
0.008
33.3%
CLA
0.006
-14.3%
RKB
0.004
33.3%
DXN
0.19
-13.6%
TLG
0.28
33.3%
OCL
6.75
-13.5%
WHK
0.004
33.3%
EM3
0.165
-13.2%
ENN
0.098
32.4%
BMM
0.053
-13.1%
TRJ
0.28
27.3%
CDE
0.007
-12.5%
M24
0.019
26.7%
BLG
0.365
-12%
PIQ
0.2
25%
VBS
0.115
-11.5%
X2M
0.005
25%
QOR
0.24
-11.1%
AXN
0.036
24.1%
FGR
0.062
-10.1%
ATS
0.021
23.5%
ATC
0.009
-10%
LGM
0.125
22.5%
CPO
0.009
-10%
EV1
0.011
22.2%
CVB
0.018
-10%
NRX
0.011
22.2%
OVT
0.009
-10%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Far East Gold (ASX:FEG): Advancing Idenburg Gold Project and takeover offer response

Transcription of The Stock Network Interview with Starpharma Far East Gold (ASX:FEG), Managing Director & CEO Shane Menere Lel Smits: Far East Gold is entering a pivotal period as it advances the flagship Eidenberg Gold project in Papua province, Indonesia, while simultaneously responding to an unsolicited takeover offer from Shangier Gold. The company has advanced […]

Mesoblast (ASX:MSB, Nasdaq:MESO): Commercial traction, pipeline milestones and future catalysts

Transcription of The Stock Network Interview with Mesoblast (ASX:MSB, Nasdaq:MESO), CEO and Managing Director Dr Silviu Itescu Lel Smits: Mesoblast has entered a new chapter following the launch of Ryoncil, with quarterly revenues growing and operating cash burn declining. At the same time, Mesoblast is advancing several late-stage programs across inflammatory diseases, chronic low back […]

Starpharma (ASX:SPL,US OTC:SPHRY:SPL): Leading science-led businesses with diverse & resilient teams

Transcription of The Stock Network Interview with Starpharma (ASX:SPL,US OTC:SPHRY:SPL), Chief Executive Officer Cheryl Maley Lel Smits: Starpharma is an innovative biotechnology company advancing dendrima technology to improve patient outcomes in areas including oncology. Alongside its scientific innovation, Starpharma is operating in a sector defined by long development cycles, evolving data, changing priorities and high […]

Hot, Not & Doing: BDX, IVG, KRR, COD, MEM, LTP, ORP, AEU & PEC

What’s Hot:BDX, IVG, KRR, COD, MEM, LTP, ORP, AEU & PEC What’s Not: MAY What’s Hot BDX – BCAL Diagnostics Limited today closed up 55% to finish at 9.3c on $2m stock traded. The reason they were up today was because they announced the development of BREASTEST Monitor, a new blood test for evaluating women […]

Pengana Private Equity Trust (ASX:PE1): Maximising mega IPOs from SpaceX to AI innovation

Transcription of The Stock Network Interview with Pengana Private Equity Trust (ASX:PE1), Investment Specialist William Dougall Lel Smits: Pengana Private Equity Trust is a diversified portfolio of institutional quality global private equity and private credit opportunities typically reserved for large institutional investors made available to Australian investors through the ASX. Following a positive May return, […]

Hot, Not & Doing: BST, VHL, X2M, PEC, LTP & OD6

What’s Hot: BST, VHL, X2M, PEC, LTP & OD6 What’s Not: ENN, KSN & LRV BST – Boresight Limited today closed up another 70% to finish at 54.5c on $6.5m stock traded. There was no news out today but yesterday they listed after raising $8m @ 20c through CPS Capital. VHL – Vitasora Health Limited today closed up 30% […]

Chariot Resources (ASX:CC9) Expands McDermitt lithium footprint as lithium market conditions improve

Transcription of The Stock Network Interview with Chariot Resources (ASX:CC9), Managing Director, Shanthar Pathmanathan Lel Smits: Chariot Resources has significantly expanded its strategic position in the McDermott Caldera after staking 573 additional claims at its Resurgent East project in Nevada, Oregon. The move nearly doubles the company’s landholding following a disciplined consolidation during the lithium […]

Ionic Rare Earths (ASX:IXR): Building a secure Western rare earth supply chain

Transcription of The Stock Network Interview with Ionic Rare Earths (ASX:IXR), Managing Director, Tim Harrison Lel Smits: Ionic Rare Earths is positioning itself at the centre of the global push for secure and sustainable rare earth supply chains through its patented magnet recycling and refining technology. The company is focused on recovering and refining critical […]